deCODE chemistry & biostructures conducts drug discovery and development for pharmaceutical and biotechnology companies using an integrated platform of structural biology and chemistry technologies. Our collaborations are designed to help clients to focus their resources on developing small molecule therapeutics that have the greatest promise of efficacy, selectivity, and safety in the clinic. We manage projects on tight timelines typically achieving IND in two to three years after initiation. From beginning to end, we offer clients access to a wide range of capabilities and expertise to achieve that goal within their own drug development programs.